Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Timothy Waxweiler

Concepts (135)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Four-Dimensional Computed Tomography
3
2021
38
0.680
Why?
Pulmonary Ventilation
3
2021
80
0.560
Why?
Re-Irradiation
1
2016
10
0.490
Why?
Brain Neoplasms
4
2023
1325
0.490
Why?
Radiotherapy Planning, Computer-Assisted
4
2021
150
0.390
Why?
Lung Neoplasms
4
2023
2675
0.390
Why?
Sarcoma
1
2015
209
0.370
Why?
Radiotherapy, Intensity-Modulated
3
2018
143
0.360
Why?
Clinical Trials as Topic
1
2017
1064
0.350
Why?
Radiotherapy, Conformal
3
2017
75
0.340
Why?
Prostatic Neoplasms
5
2015
972
0.320
Why?
Radiation Pneumonitis
2
2021
31
0.310
Why?
Neoplasm Recurrence, Local
1
2016
1160
0.300
Why?
SEER Program
6
2015
233
0.220
Why?
Head and Neck Neoplasms
2
2022
563
0.220
Why?
Risk Assessment
1
2015
3712
0.220
Why?
Oncogene Addiction
1
2023
6
0.190
Why?
Antineoplastic Agents
3
2023
2219
0.170
Why?
Neoplasm Staging
4
2018
1488
0.150
Why?
Protein-Tyrosine Kinases
1
2023
429
0.150
Why?
Proto-Oncogene Proteins
1
2023
616
0.150
Why?
Radiosurgery
1
2022
398
0.140
Why?
Carcinoma, Renal Cell
1
2021
231
0.140
Why?
Papillomavirus Infections
1
2022
345
0.140
Why?
Smokers
1
2018
139
0.130
Why?
Chemoradiotherapy, Adjuvant
1
2016
44
0.120
Why?
Kidney Neoplasms
1
2021
419
0.120
Why?
Salivary Gland Neoplasms
1
2016
39
0.120
Why?
Respiration
1
2017
208
0.120
Why?
Neoplasm Grading
2
2014
313
0.120
Why?
Treatment Outcome
8
2023
11821
0.120
Why?
Analysis of Variance
2
2015
1298
0.110
Why?
Neoplasms, Germ Cell and Embryonal
1
2016
76
0.110
Why?
Testicular Neoplasms
1
2016
108
0.110
Why?
Organ Sparing Treatments
1
2015
37
0.110
Why?
Medically Uninsured
1
2015
134
0.110
Why?
Oligodendroglioma
1
2014
15
0.110
Why?
Brachytherapy
1
2015
132
0.110
Why?
Prognosis
4
2018
4351
0.100
Why?
Radiotherapy, Adjuvant
1
2014
222
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1195
0.100
Why?
Astrocytoma
1
2014
128
0.100
Why?
Retrospective Studies
6
2017
17438
0.100
Why?
Insurance, Health
1
2015
318
0.090
Why?
Humans
19
2023
146342
0.090
Why?
Benzimidazoles
1
2013
191
0.090
Why?
Retinol-Binding Proteins
1
2011
17
0.090
Why?
Eye Abnormalities
1
2011
17
0.090
Why?
Infant
2
2016
10114
0.080
Why?
Chemoradiotherapy
1
2013
238
0.080
Why?
Medicaid
1
2015
477
0.080
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2013
139
0.080
Why?
Lymph Nodes
1
2014
511
0.080
Why?
Aged
11
2023
26432
0.080
Why?
Eye Proteins
1
2011
93
0.080
Why?
Survival Rate
4
2016
2092
0.080
Why?
Child, Preschool
2
2016
11913
0.080
Why?
Eye
1
2011
112
0.080
Why?
Male
15
2023
73396
0.080
Why?
Neoplasm Proteins
1
2013
444
0.080
Why?
Adolescent
4
2016
22557
0.070
Why?
Algorithms
1
2017
1849
0.070
Why?
Melanoma
1
2015
765
0.070
Why?
Skin Neoplasms
1
2015
806
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
1998
0.070
Why?
Prospective Studies
2
2018
8123
0.070
Why?
Kaplan-Meier Estimate
3
2015
970
0.070
Why?
Middle Aged
10
2023
36619
0.060
Why?
United States
5
2015
16136
0.060
Why?
Radiotherapy Dosage
2
2018
289
0.060
Why?
Adult
7
2023
41087
0.060
Why?
Child
2
2016
22693
0.060
Why?
Young Adult
3
2016
14330
0.050
Why?
Colorectal Neoplasms
1
2013
874
0.050
Why?
Propensity Score
2
2016
376
0.050
Why?
Female
9
2023
79499
0.050
Why?
Neoplasm Metastasis
2
2018
693
0.050
Why?
Infant, Newborn
1
2015
6460
0.050
Why?
Prostate-Specific Antigen
2
2014
162
0.050
Why?
Follow-Up Studies
3
2016
5439
0.050
Why?
Proportional Hazards Models
2
2015
1331
0.040
Why?
Central Nervous System
1
2023
278
0.040
Why?
ErbB Receptors
1
2023
636
0.040
Why?
Neoadjuvant Therapy
1
2022
475
0.040
Why?
Aged, 80 and over
3
2016
8391
0.040
Why?
Magnetic Resonance Imaging
2
2023
3926
0.040
Why?
Drug Administration Schedule
1
2021
790
0.040
Why?
Radiotherapy, Image-Guided
1
2018
40
0.030
Why?
Cetuximab
1
2018
110
0.030
Why?
Age Factors
2
2016
3347
0.030
Why?
Phthalazines
1
2018
64
0.030
Why?
DNA Mutational Analysis
1
2018
410
0.030
Why?
Skin Ulcer
1
2015
15
0.030
Why?
Piperazines
1
2018
368
0.030
Why?
Antibodies, Monoclonal
1
2022
1512
0.030
Why?
Combined Modality Therapy
1
2018
1271
0.030
Why?
Radiation Protection
1
2015
41
0.030
Why?
Marital Status
1
2014
47
0.030
Why?
Prostatectomy
1
2014
93
0.020
Why?
Comet Assay
1
2013
14
0.020
Why?
HT29 Cells
1
2013
37
0.020
Why?
Organoplatinum Compounds
1
2013
65
0.020
Why?
Disease Progression
1
2021
2867
0.020
Why?
HCT116 Cells
1
2013
78
0.020
Why?
Radiotherapy
1
2014
209
0.020
Why?
Time Factors
2
2014
7109
0.020
Why?
Lymphatic Metastasis
1
2014
335
0.020
Why?
Camptothecin
1
2013
139
0.020
Why?
Research Design
1
2018
1143
0.020
Why?
Disease-Free Survival
1
2014
778
0.020
Why?
Fluorouracil
1
2013
231
0.020
Why?
Microscopy, Interference
1
2011
8
0.020
Why?
Tumor Burden
1
2013
326
0.020
Why?
Transcriptome
1
2018
1068
0.020
Why?
Retinal Cone Photoreceptor Cells
1
2011
20
0.020
Why?
Mice, Nude
1
2013
668
0.020
Why?
Refractive Errors
1
2011
36
0.020
Why?
S Phase
1
2011
77
0.020
Why?
Biomarkers, Tumor
1
2018
1339
0.020
Why?
Glioblastoma
1
2014
350
0.020
Why?
Feasibility Studies
1
2015
1135
0.020
Why?
Organ Size
1
2011
465
0.020
Why?
Microscopy, Confocal
1
2011
322
0.020
Why?
DNA Damage
1
2013
439
0.020
Why?
Xenograft Model Antitumor Assays
1
2013
930
0.020
Why?
Sex Factors
1
2014
2107
0.020
Why?
Lung
1
2021
4122
0.020
Why?
Histones
1
2013
670
0.020
Why?
Colorado
1
2015
4595
0.010
Why?
Mice
2
2013
18297
0.010
Why?
Mice, Knockout
1
2011
3125
0.010
Why?
Cross-Sectional Studies
1
2015
5899
0.010
Why?
Apoptosis
1
2011
2439
0.010
Why?
Mice, Inbred C57BL
1
2011
6034
0.010
Why?
Animals
2
2013
38106
0.010
Why?
Waxweiler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)